FREZENT Biological Solutions
Eliminating the threat of recurrent cancer.
New York, United States · Founded 2017 · $100K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2017
- Website
- frezent.com
- Total Funding
- $100K
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
FREZENT Biological Solutions is a New York-based preclinical oncology therapeutics company founded by Dr. Natasha Shtraizent and Dr. Lina Freage-Kahn. Its mission is to eliminate the threat of recurrent cancer by developing novel bispecific antibodies and biological inhibitors targeting cancer-specific lipid metabolism pathways. The company focuses on extending lives of advanced-stage cancer patients by targeting dormant cancer cells that drive recurrence. FREZENT was selected for the 2025 MSK Therapeutics Accelerator cohort at Memorial Sloan Kettering Cancer Center.
Summary
FREZENT Biological Solutions is a Biotech company based in New York, United States, founded in 2017. It has raised $100K in total across 1 round. Investors include SOSV, IndieBio and New York Ventures.
Funding History
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/frezent-biological-solutions"><img src="https://indexed.vc/api/badge/company/frezent-biological-solutions" alt="FREZENT Biological Solutions on Indexed.vc" width="260" height="76" /></a>